Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea · Delayed Price · Currency is KRW 33,250
+950 (2.94%)
At close: Aug 24, 2026
Next Biomedical Market Cap
Next Biomedical has a market cap or net worth of 267.36 billion as of August 24, 2026. Its market cap has decreased by -40.94% in one year.
Market Cap
267.36B
Enterprise Value
239.32B
Revenue
17.79B
Ranking
n/a
PE Ratio
1,149.61
Stock Price
33,250.00
ChartMarket Cap Chart
Since August 20, 2024, Next Biomedical's market cap has increased from 189.79B to 267.36B, an increase of 40.87%. That is a compound annual growth rate of 18.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 267.36B | -63.55% |
| Dec 30, 2025 | 733.43B | 121.21% |
| Dec 30, 2024 | 331.55B | 74.69% |
| Aug 20, 2024 | 189.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ASTERASYS Co.,Ltd | 201.31B |
| MEDIANA Co.,Ltd | 160.89B |
| Mezoo | 129.65B |
| L&K Biomed | 94.21B |
| Dynamic solution | 83.12B |
| Remed | 80.79B |
| Hironic | 65.62B |
| SELVAS Healthcare | 61.47B |